0001209191-20-047529.txt : 20200819 0001209191-20-047529.hdr.sgml : 20200819 20200819165616 ACCESSION NUMBER: 0001209191-20-047529 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200817 FILED AS OF DATE: 20200819 DATE AS OF CHANGE: 20200819 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Crowley John F CENTRAL INDEX KEY: 0001400973 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33497 FILM NUMBER: 201117617 MAIL ADDRESS: STREET 1: C/O AMICUS THERAPEUTICS, INC. STREET 2: 1 CEDAR BROOK DRIVE CITY: CRANBURY STATE: NJ ZIP: 08512 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AMICUS THERAPEUTICS, INC. CENTRAL INDEX KEY: 0001178879 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 200422823 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1 CEDAR BROOK DRIVE CITY: CRANBURY STATE: NJ ZIP: 08512 BUSINESS PHONE: (609) 662-2000 MAIL ADDRESS: STREET 1: 1 CEDAR BROOK DRIVE CITY: CRANBURY STATE: NJ ZIP: 08512 FORMER COMPANY: FORMER CONFORMED NAME: AMICUS THERAPEUTICS INC DATE OF NAME CHANGE: 20020729 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-08-17 0 0001178879 AMICUS THERAPEUTICS, INC. FOLD 0001400973 Crowley John F C/O AMICUS THERAPEUTICS, INC. 1 CEDAR BROOK DRIVE CRANBURY NJ 08512 1 1 0 0 Chairman & CEO Common Stock 2020-08-17 4 M 0 20000 5.13 A 880713 D Common Stock 2020-08-17 4 S 0 20000 14.8907 D 860713 D Common Stock 64895 I By Trust Stock Options (right to buy) 5.13 2020-08-17 4 M 0 20000 0.00 D 2027-01-03 Common Stock 20000 62485 D The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. This price is the weighted average price for the transactions reported on this line. The prices for the transactions reported on this line range from $14.46 to $15.02 inclusive. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. As of August 17, 2020, 53,056 options were fully vested and exercisable and 29,429 remained unvested from this individual 2017 grant. In addition to the reported transactions, Mr. Crowley also has approximately 1.52 million options outstanding and exercisable at various strike prices. /s/ Christian Formica, Attorney-in-Fact 2020-08-19